FINWIRES · TerminalLIVE
FINWIRES

米イラン間の停戦の不安定さがトレーダーの警戒感を招き、米株先物は取引開始前に横ばいとなった。

-- 金曜日の取引開始前、米国株先物は横ばいだった。トレーダーらは、米国とイランの間で2週間続いた不安定な停戦を警戒していた。 ダウ工業株30種平均先物は横ばい、S&P500先物は0.1%高、ナスダック先物は0.2%高だった。 ホルムズ海峡は依然として閉鎖されており、イスラエルはレバノンのヒズボラと交戦を続けている。土曜午前にイスラマバードで米イラン協議が予定されているにもかかわらず、こうした状況が続いている。イスラエルは、ヒズボラの武装解除と国内での攻撃終結を目指し、レバノン政府との協議を開始すると表明している。 原油価格は上昇し、北海ブレント原油(期近物)は0.1%高の1バレル95.99ドル、米国産WTI原油は0.2%高の1バレル98.06ドルとなった。 ブルームバーグがまとめた予測によると、東部時間午前8時30分に発表予定の3月の消費者物価指数は、2月は0.9%上昇と予想されており、1月の0.3%上昇から低下する見込みです。一方、ミシガン大学が発表する4月の消費者信頼感指数は51.5%と予想されており、前回の53.3%から低下する見込みです。また、2月の製造業新規受注はマイナス0.2%と予想されており、前回の0.1%から低下する見込みです。 これら2つの指標は、東部時間午前10時に発表される予定です。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB